Medicare Enrolled
Dr. Elias Iliadis, MD
Cardiovascular Disease · Voorhees, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Iliadis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Iliadis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Iliadis
Dr. Elias Iliadis is a cardiovascular disease specialist in Voorhees, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Iliadis performed 2,032 Medicare services across 1,606 unique beneficiaries.
Between the years covered by Open Payments, Dr. Iliadis received a total of $139,368 from 47 pharmaceutical and/or device companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Iliadis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 2,032 Medicare services
$139,368 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,032
Medicare services
Bottom 35% in NJ for cardiovascular disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
1,606
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~107 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
498 | $97 | $400 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
437 | $11 | $83 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
357 | $162 | $606 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
150 | $207 | $742 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
121 | $142 | $536 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
71 | $106 | $450 |
| Cardiac catheterization | 61 | $197 | $1,073 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
54 | $160 | $619 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
40 | $101 | $617 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
38 | $464 | $1,927 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
28 | $66 | $279 |
| Right heart catheterization A procedure where a thin, flexible tube is inserted into the right side of the heart to measure pressure and oxygen levels. |
27 | $81 | $1,409 |
| New patient office visit, complex (60-74 min) | 26 | $183 | $662 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts This procedure uses sound waves to create images of the aorta, vena cava, groin vessels, or bypass grafts. It allows for the visualization of these blood vessels and any surgical grafts. |
24 | $93 | $395 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
21 | $98 | $395 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
18 | $156 | $1,078 |
| Pulmonary artery injection during heart catheterization An injection is administered to image the pulmonary artery while a heart catheterization is being performed. |
18 | $40 | $514 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
17 | $241 | $798 |
| Artery clot removal and dissolution with fluoroscopy This procedure removes and dissolves a blood clot from an artery or artery graft using fluoroscopic guidance. It is performed on the initial vessel treated. |
15 | $395 | $19,301 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
11 | $61 | $233 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.2% high complexity
31.4% medium
54.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$139,368
Total received (2018-2024)
Avg $19,910/year across 7 years
Top 1% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
860
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$121,347 (87.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,231 (10.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,791 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$21,493
2023
$44,289
2022
$34,743
2021
$16,084
2020
$6,566
2019
$11,375
2018
$4,817
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Penumbra, Inc.
$16,069
Janssen Pharmaceuticals, Inc
$1,324
ShockWave Medical, Inc
$596
Abbott Laboratories
$495
ATRICURE, INC.
$485
Boston Scientific Corporation
$417
Terumo Medical Corporation
$372
ABIOMED
$273
Inari Medical, Inc.
$244
Alnylam Pharmaceuticals Inc.
$210
Novartis Pharmaceuticals Corporation
$164
AngioDynamics, Inc.
$162
Amgen Inc.
$133
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$115
Medtronic, Inc.
$107
PFIZER INC.
$99
CVRx, Inc.
$40
Chiesi USA, Inc.
$34
Actelion Pharmaceuticals US, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Biosense Webster, Inc.
$26
CORDIS US CORP.
$20
Kestra Medical Technology Services, Inc.
$15
E.R. Squibb & Sons, L.L.C.
$14
Philips North America LLC
$13
Top 3 companies account for 83.7% of 2024 payments
All-time payments by company (2018-2024) ›
Penumbra, Inc.
$58,272
Janssen Pharmaceuticals, Inc
$36,657
AstraZeneca Pharmaceuticals LP
$13,802
PFIZER INC.
$7,167
E.R. Squibb & Sons, L.L.C.
$5,978
ABIOMED
$3,322
Philips Electronics North America Corporation
$2,600
Boston Scientific Corporation
$1,039
Abbott Laboratories
$974
Inari Medical, Inc.
$916
CryoLife, Inc.
$858
Amgen Inc.
$784
Cardiovascular Systems Inc.
$771
ATRICURE, INC.
$665
ShockWave Medical, Inc
$635
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$599
Medtronic Vascular, Inc.
$418
Medtronic, Inc.
$378
Terumo Medical Corporation
$372
CARDIVA MEDICAL, INC.
$270
Boehringer Ingelheim Pharmaceuticals, Inc.
$254
AngioDynamics, Inc.
$236
Novartis Pharmaceuticals Corporation
$233
Alnylam Pharmaceuticals Inc.
$229
Kestra Medical Technology Services, Inc.
$191
EKOS Corporation
$173
W. L. Gore & Associates, Inc.
$170
Cardinal Health 200, LLC
$168
Chiesi USA, Inc.
$162
BOSTON SCIENTIFIC CORPORATION
$158
Merck Sharp & Dohme LLC
$151
Bard Peripheral Vascular, Inc.
$140
Janssen Scientific Affairs, LLC
$120
Biosense Webster, Inc.
$88
PORTOLA PHARMACEUTICALS, INC.
$80
Actelion Pharmaceuticals US, Inc.
$63
Merck Sharp & Dohme Corporation
$54
Shockwave Medical, Inc
$46
CVRx, Inc.
$40
Change Healthcare Technologies, LLC
$25
CORDIS US CORP.
$20
Siemens Medical Solutions USA, Inc.
$19
Regeneron Healthcare Solutions, Inc.
$17
Kiniksa Pharmaceuticals, Ltd.
$14
Philips North America LLC
$13
iRhythm Technologies, Inc.
$13
Gilead Sciences, Inc.
$11
Top 3 companies account for 78.0% of all-time payments
Associated products mentioned in payments ›
(6366) Sync · (6571) Eagle Eye · (6577) Visions 014 · (6585) Omniwire · (9520) IGT Devices Undivided · (BR1) Coronary Specialty Balloon · ALPHAVAC · AMVUTTRA · ANDEXXA · Arcalyst · Artis icono floor · Assure WCD · Azure · BEVYXXA · BRILINTA · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIVA VASCADE 5F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CLEVIPREX · COMET · CT THROMBECTOMY SYSTEM KIT · Cardiva VASCADE 6/7F VCS · Carto 3 · Change Healthcare Cardiology · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · Diamondback Peripheral · EKOSONIC · ELIQUIS · ELUVIA · ENTRESTO · EP-WorkMate Recording System · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · EXOSEAL · EkoSonic · FARXIGA · FLOWTRIEVER CATHETER · FRONTRUNNER XP CTO Catheter · GENERAL STENTS · GLIDESHEATH SLENDER · GORE CARDIOFORM Septal Occluder · General - Thrombectomy · HAWKONE · Impella · Indigo · Indigo System · JARDIANCE · KENGREAL · LEQVIO · LifeVest · METACROSS OTW · MynxGrip Vascular Closure Device · NAVICROSS · NAVITOR · OCTARAY MAPPING CATHETER · ONYX FRONTIER · OPSUMIT · OPSUMIT MACITENTAN · On-X · Optis Coronary Imaging System · PRADAXA · PRECISE PRO RX Carotid Stent System · PROMUS · PressureWire FFR · QDOT MICRO Catheter · Quadra Allure MP RF CRT Pacemkr · RESOLUTE ONYX · ROTABLATOR · RUBY Coil · Ranexa · Ranger · Repatha · Resolute · Reveal LINQ · Rotarex · S · S.M.A.R.T. · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · SYMPLICITY G3 · SYNERGY · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Smart Coil · Tryton Side Branch Stent · VERQUVO · VIGILANT · VYNDAQEL · WAINUA · WOLVERINE · XARELTO · XIENCE SKYPOINT · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for cardiovascular disease in NJ.
Geographic Context
Cardiologists within 10 mi
617
Per 100K population
117.7
County median income
$86,384
Nearest hospital
WEST JERSEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Iliadis is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Iliadis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Iliadis performed 498 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Iliadis receive payments from pharmaceutical companies?
Yes. Dr. Iliadis received a total of $139,368 from 47 companies across 860 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Iliadis's costs compare to other cardiologists in Voorhees?
Dr. Iliadis's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Iliadis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Voorhees
Browse cardiologists in Voorhees ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology